Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Correction to: Dysplastic features seen in a patient with acute myeloid leukemia harboring the KMT2A-TET1 fusion gene.

Kawai H, Matsushita H, Aoyama Y, Matsui K, Onizuka M, Ando K.

Int J Hematol. 2018 Aug;108(2):232. doi: 10.1007/s12185-018-2476-5.

PMID:
29948955
2.

Additional cytogenetic abnormalities with Philadelphia chromosome-positive acute lymphoblastic leukemia on allogeneic stem cell transplantation in the tyrosine kinase inhibitor era.

Akahoshi Y, Mizuta S, Shimizu H, Uchida N, Fukuda T, Kanamori H, Onizuka M, Ozawa Y, Ohashi K, Ohta S, Eto T, Tanaka J, Atsuta Y, Kako S.

Biol Blood Marrow Transplant. 2018 Jun 13. pii: S1083-8791(18)30318-5. doi: 10.1016/j.bbmt.2018.06.006. [Epub ahead of print]

PMID:
29908230
3.

Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells?

Nakasone H, Tabuchi K, Uchida N, Ohno Y, Matsuhashi Y, Takahashi S, Onishi Y, Onizuka M, Kobayashi H, Fukuda T, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Yabe H, Kanda Y.

Br J Haematol. 2018 May 29. doi: 10.1111/bjh.15418. [Epub ahead of print] No abstract available.

PMID:
29808925
4.

Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene.

Kawai H, Matsushita H, Aoyama Y, Matsui K, Onizuka M, Ando K.

Int J Hematol. 2018 May 9. doi: 10.1007/s12185-018-2469-4. [Epub ahead of print] No abstract available. Erratum in: Int J Hematol. 2018 Jun 12;:.

PMID:
29744807
5.

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study.

Harada Y, Nagata Y, Kihara R, Ishikawa Y, Asou N, Ohtake S, Miyawaki S, Sakura T, Ozawa Y, Usui N, Kanamori H, Ito Y, Imai K, Suehiro Y, Kobayashi S, Kitamura K, Sakaida E, Onizuka M, Takeshita A, Ishida F, Suzushima H, Ishizawa K, Naoe T, Matsumura I, Miyazaki Y, Ogawa S, Kiyoi H; Japan Adult Leukemia Study Group JALSG.

Leuk Res. 2018 Mar;66:20-27. doi: 10.1016/j.leukres.2018.01.008. Epub 2018 Jan 17.

PMID:
29360622
6.

[Impact of genetic polymorphisms on post-transplant complications].

Onizuka M.

Rinsho Ketsueki. 2017;58(12):2432-2439. doi: 10.11406/rinketsu.58.2432. Japanese.

PMID:
29332880
7.

Clinicopathological Analysis of 320 Cases of Diffuse Large B-cell Lymphoma Using the Hans Classifier.

Ichiki A, Carreras J, Miyaoka M, Kikuti YY, Jibiki T, Tazume K, Watanabe S, Sasao T, Obayashi Y, Onizuka M, Ohmachi K, Yoshiba F, Shirasugi Y, Ogawa Y, Kawada H, Nakamura N, Ando K.

J Clin Exp Hematop. 2017;57(2):54-63. doi: 10.3960/jslrt.17029.

8.

Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults.

Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Hidaka M, Kobayashi N, Iwato K, Sakura T, Onizuka M, Ozawa Y, Eto T, Kurokawa M, Kahata K, Uchida N, Atsuta Y, Mizuta S, Kako S.

Am J Hematol. 2018 Jan;93(1):47-57. doi: 10.1002/ajh.24933. Epub 2017 Nov 9.

PMID:
28983949
9.

NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.

Hara R, Onizuka M, Matsusita E, Kikkawa E, Nakamura Y, Matsushita H, Ohgiya D, Murayama H, Machida S, Ohmachi K, Shirasugi Y, Ogawa Y, Kawada H, Ando K.

Int J Hematol. 2017 Nov;106(5):666-674. doi: 10.1007/s12185-017-2294-1. Epub 2017 Aug 9.

PMID:
28795321
10.

Factors affecting the interaction between carbon nanotubes and redox enzymes in direct electron transfer-type bioelectrocatalysis.

Xia HQ, Kitazumi Y, Shirai O, Ozawa H, Onizuka M, Komukai T, Kano K.

Bioelectrochemistry. 2017 Dec;118:70-74. doi: 10.1016/j.bioelechem.2017.07.003. Epub 2017 Jul 13.

PMID:
28732287
11.

GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia.

Terakura S, Kuwatsuka Y, Yamasaki S, Wake A, Kanda J, Inamoto Y, Mizuta S, Yamaguchi T, Uchida N, Kouzai Y, Aotsuka N, Ogawa H, Kanamori H, Nishiwaki K, Miyakoshi S, Onizuka M, Amano I, Fukuda T, Ichinohe T, Atsuta Y, Murata M, Teshima T.

Bone Marrow Transplant. 2017 Sep;52(9):1261-1267. doi: 10.1038/bmt.2017.116. Epub 2017 Jun 12.

PMID:
28604665
12.

Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.

Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Ohashi K.

Am J Hematol. 2017 Sep;92(9):902-908. doi: 10.1002/ajh.24793. Epub 2017 Jun 9.

PMID:
28543934
13.

Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myelogenous Leukemia.

Mizutani M, Takami A, Hara M, Mizuno S, Yanada M, Chou T, Uchiyama H, Ohashi K, Miyamoto T, Ozawa Y, Imataki O, Kobayashi N, Uchida N, Kanamori H, Kamimura T, Eto T, Onizuka M, Tanaka J, Atsuta Y, Yano S.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1447-1454. doi: 10.1016/j.bbmt.2017.05.008. Epub 2017 May 19.

PMID:
28533061
14.

The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.

Horio T, Mizuno S, Uchino K, Mizutani M, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Takami A.

Transpl Immunol. 2017 Jun;42:34-39. doi: 10.1016/j.trim.2017.05.003. Epub 2017 May 6.

PMID:
28487238
15.

Toll-like receptor genetic variations in bone marrow transplantation.

Uchino K, Mizuno S, Sato-Otsubo A, Nannya Y, Mizutani M, Horio T, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Ogawa S, Takami A.

Oncotarget. 2017 Jul 11;8(28):45670-45686. doi: 10.18632/oncotarget.17315.

16.

Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults.

Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Kawakita T, Mori T, Hoshino T, Onizuka M, Ozawa Y, Yoshida S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S; Japan Society for Haematopoietic Cell Transplantation.

Br J Haematol. 2017 Jul;178(1):106-111. doi: 10.1111/bjh.14652. Epub 2017 Apr 25.

PMID:
28439877
17.

Cortical cells reveal APP as a new player in the regulation of GABAergic neurotransmission.

Doshina A, Gourgue F, Onizuka M, Opsomer R, Wang P, Ando K, Tasiaux B, Dewachter I, Kienlen-Campard P, Brion JP, Gailly P, Octave JN, Pierrot N.

Sci Rep. 2017 Mar 23;7(1):370. doi: 10.1038/s41598-017-00325-2.

18.

Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S.

Blood. 2017 Apr 27;129(17):2347-2358. doi: 10.1182/blood-2016-12-754796. Epub 2017 Feb 21.

19.

Successful treatment with low-dose nivolumab in refractory Hodgkin lymphoma after allogeneic stem cell transplantation.

Onizuka M, Kojima M, Matsui K, Machida S, Toyosaki M, Aoyama Y, Kawai H, Amaki J, Hara R, Ichiki A, Ogawa Y, Kawada H, Nakamura N, Ando K.

Int J Hematol. 2017 Jul;106(1):141-145. doi: 10.1007/s12185-017-2181-9. Epub 2017 Jan 17.

PMID:
28097534
20.

Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.

Fujiwara H, Fuji S, Wake A, Kato K, Takatsuka Y, Fukuda T, Taguchi J, Uchida N, Miyamoto T, Hidaka M, Miyazaki Y, Tomoyose T, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2017 Mar;52(3):484-488. doi: 10.1038/bmt.2016.313. Epub 2017 Jan 9. No abstract available.

PMID:
28067877
21.

Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Machida S, Onizuka M, Toyosaki M, Aoyama Y, Kawai H, Amaki J, Hara R, Ichiki A, Ogawa Y, Kawada H, Ando K.

Bone Marrow Transplant. 2017 Feb;52(2):307-309. doi: 10.1038/bmt.2016.270. Epub 2016 Nov 28. No abstract available.

PMID:
27892947
22.

Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation.

Nakasone H, Fuji S, Yakushijin K, Onizuka M, Shinohara A, Ohashi K, Miyamura K, Uchida N, Takanashi M, Ichinohe T, Atsuta Y, Fukuda T, Ogata M; Complication Working Group of Japanese Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2017 Feb;92(2):171-178. doi: 10.1002/ajh.24613.

23.

Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia.

Yamasaki S, Hirakawa A, Aoki J, Uchida N, Fukuda T, Ogawa H, Ohashi K, Kondo T, Eto T, Kanamori H, Okumura H, Iwato K, Ichinohe T, Kanda J, Onizuka M, Kuwatsuka Y, Yanada M, Atsuta Y, Takami A, Yano S.

Ann Hematol. 2017 Feb;96(2):289-297. doi: 10.1007/s00277-016-2872-y. Epub 2016 Nov 12.

PMID:
27838773
24.

Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.

Kobayashi R, Mitsui T, Fujita N, Osumi T, Aoki T, Aoki K, Suzuki R, Fukuda T, Miyamoto T, Kato K, Nakamae H, Goto H, Eto T, Inoue M, Mori T, Terui K, Onizuka M, Koh K, Koga Y, Ichinohe T, Sawada A, Atsuta Y, Suzumiya J.

Int J Hematol. 2017 Mar;105(3):369-376. doi: 10.1007/s12185-016-2120-1. Epub 2016 Oct 27.

PMID:
27787746
25.

Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.

Mitsuhashi K, Kako S, Shigematsu A, Atsuta Y, Doki N, Fukuda T, Kanamori H, Onizuka M, Takahashi S, Ozawa Y, Kurokawa M, Inoue Y, Nagamura-Inoue T, Morishima Y, Mizuta S, Tanaka J; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2194-2200. doi: 10.1016/j.bbmt.2016.09.007. Epub 2016 Sep 13.

26.

A Retrospective Study on the Effectiveness of Switching to Oral Methadone for Relieving Severe Cancer-Related Neuropathic Pain and Limiting Adjuvant Analgesic Use in Japan.

Sugiyama Y, Sakamoto N, Ohsawa M, Onizuka M, Ishida K, Murata Y, Iio A, Sugano K, Maeno K, Takeyama H, Akechi T, Kimura K.

J Palliat Med. 2016 Oct;19(10):1051-1059. Epub 2016 Jul 12.

PMID:
27404399
27.

Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.

Uchino K, Mizuno S, Mizutani M, Horio T, Hanamura I, Espinoza JL, Matsuo K, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori TM, Takami A; Japan Marrow Donor Program.

Transpl Immunol. 2016 Sep;38:60-6. doi: 10.1016/j.trim.2016.06.002. Epub 2016 Jun 28.

PMID:
27369862
28.

Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.

Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S, Kanamori H, Hidaka M, Sakura T, Onizuka M, Kobayashi N, Sawa M, Eto T, Matsuhashi Y, Kato K, Ichinohe T, Atsuta Y, Miyamura K; Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2016 May;91(5):E284-92. doi: 10.1002/ajh.24340. Epub 2016 Mar 28.

29.

Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.

Mori T, Koh H, Onishi Y, Kako S, Onizuka M, Kanamori H, Ozawa Y, Kato C, Iida H, Suzuki R, Ichinohe T, Kanda Y, Maeda T, Nakao S, Yamazaki H.

Int J Hematol. 2016 Apr;103(4):461-8. doi: 10.1007/s12185-016-1960-z. Epub 2016 Feb 24.

PMID:
26910242
30.

Bacterial Pneumonia-induced Persistent Remission of Severe Immune Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation.

Onizuka M, Matsushita H, Machida S, Toyosaki M, Amaki J, Aoyama Y, Miyamoto M, Ando K.

Intern Med. 2016;55(2):179-83. doi: 10.2169/internalmedicine.55.4724. Epub 2016 Jan 15.

31.

Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia.

Aoki J, Kanamori H, Tanaka M, Yamasaki S, Fukuda T, Ogawa H, Iwato K, Ohashi K, Okumura H, Onizuka M, Maesako Y, Teshima T, Kobayashi N, Morishima Y, Hirokawa M, Atsuta Y, Yano S, Takami A.

Am J Hematol. 2016 Mar;91(3):302-7. doi: 10.1002/ajh.24270. Epub 2016 Jan 11.

32.

The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDS.

Kako S, Kanda Y, Kato J, Yamamoto W, Kato S, Onizuka M, Yokota A, Tatara R, Yokoyama H, Hagihara M, Usuki K, Gotoh M, Watanabe R, Kawai N, Saitoh T, Kanamori H, Takahashi S, Okamoto S.

Hematol Oncol. 2017 Sep;35(3):341-349. doi: 10.1002/hon.2276. Epub 2015 Dec 8.

PMID:
26643559
33.

Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML.

Aoki J, Seo S, Kanamori H, Tanaka M, Fukuda T, Onizuka M, Kobayashi N, Kondo T, Sawa M, Uchida N, Iwato K, Icihnohe T, Atsuta Y, Yano S, Takami A.

Bone Marrow Transplant. 2016 Apr;51(4):604-6. doi: 10.1038/bmt.2015.297. Epub 2015 Dec 7. No abstract available.

PMID:
26642343
34.

Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.

Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T, Ohwada C, Miyamura K, Nawa Y, Kurokawa M, Mizuno I, Mori T, Onizuka M, Taguchi J, Ichinohe T, Yabe H, Morishima Y, Kato K, Suzuki R, Fukuda T.

Bone Marrow Transplant. 2016 Mar;51(3):403-9. doi: 10.1038/bmt.2015.283. Epub 2015 Nov 23.

PMID:
26595082
35.

Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.

Sato-Otsubo A, Nannya Y, Kashiwase K, Onizuka M, Azuma F, Akatsuka Y, Ogino Y, Satake M, Sanada M, Chiba S, Saji H, Inoko H, Kennedy GC, Yamamoto K, Morishima S, Morishima Y, Kodera Y, Sasazuki T, Ogawa S; Japan Marrow Donor Program.

Blood. 2015 Dec 17;126(25):2752-63. doi: 10.1182/blood-2015-03-630707. Epub 2015 Oct 2.

36.

Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.

Nomoto H, Takami A, Espinoza JL, Matsuo K, Mizuno S, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Ohtake S, Morishita E.

Int J Hematol. 2015 Oct;102(4):507-8. doi: 10.1007/s12185-015-1867-0. No abstract available.

PMID:
26351240
37.

First genetic identification of Cryptosporidium parvum subtype IIaA14G2R1in beef cattle in Brazil.

Heckler RP, Borges DG, Bacha FB, Onizuka MK, Teruya Le, Neves JP, Leal CR, de Lemos RA, Meireles MV, Borges Fde A.

Prev Vet Med. 2015 Oct 1;121(3-4):391-4. doi: 10.1016/j.prevetmed.2015.08.016. Epub 2015 Aug 29.

PMID:
26342791
38.

Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy.

Arai Y, Aoki K, Takeda J, Kondo T, Eto T, Ota S, Hashimoto H, Fukuda T, Ozawa Y, Kanda Y, Kato C, Kurokawa M, Iwato K, Onizuka M, Ichinohe T, Atsuta Y, Takami A; AML and MDS Working Group of Japan Society for Hematopoietic Cell Transplantation.

J Hematol Oncol. 2015 Sep 4;8:102. doi: 10.1186/s13045-015-0201-x.

39.

A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.

Nomoto H, Takami A, Espinoza JL, Matsuo K, Mizuno S, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Ohtake S, Morishita E.

Int J Hematol. 2015 Oct;102(4):460-70. doi: 10.1007/s12185-015-1852-7. Epub 2015 Aug 6. Erratum in: Int J Hematol. 2015 Oct;102(4):507-8.

PMID:
26246110
40.

Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.

Motohashi K, Fujisawa S, Onizuka M, Kako S, Sakaida E, Shono K, Tatara R, Doki N, Mori T, Sakura T, Aotsuka N, Fuji E, Tomita N, Kawai N, Saitoh T, Usuki K, Taguchi J, Watanabe R, Kobayashi S, Yano S, Kanamori H, Takahashi S, Okamoto S.

Bone Marrow Transplant. 2015 Nov;50(11):1476-9. doi: 10.1038/bmt.2015.142. Epub 2015 Jul 20. No abstract available.

PMID:
26191948
41.

Multispecies resistance of cattle gastrointestinal nematodes to long-acting avermectin formulations in Mato Grosso do Sul.

Borges Fde A, Borges DG, Heckler RP, Neves JP, Lopes FG, Onizuka MK.

Vet Parasitol. 2015 Sep 15;212(3-4):299-302. doi: 10.1016/j.vetpar.2015.06.015. Epub 2015 Jun 20.

PMID:
26129974
42.

[Hematopoietic stem cell transplantation for Ph positive acute lymphoblastic leukemia].

Onizuka M.

Rinsho Ketsueki. 2015 Mar;56(3):298-303. doi: 10.11406/rinketsu.56.298. Review. Japanese.

PMID:
25876783
43.

Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy.

Amaki J, Onizuka M, Ohmachi K, Aoyama Y, Hara R, Ichiki A, Kawai H, Sato A, Miyamoto M, Toyosaki M, Machida S, Kojima M, Shirasugi Y, Kawada H, Ogawa Y, Ando K.

Int J Hematol. 2015 Jun;101(6):543-53. doi: 10.1007/s12185-015-1766-4. Epub 2015 Mar 4.

PMID:
25735499
44.

A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia.

Shigematsu A, Ozawa Y, Onizuka M, Fujisawa S, Suzuki R, Atsuta Y, Hatanaka K, Masuko M, Ito T, Kobayashi N, Kato J, Miyamura K, Fukuda T, Morishima Y, Imamura M.

Transplant Direct. 2015 Mar 13;1(2):e8. doi: 10.1097/TXD.0000000000000514. eCollection 2015 Mar.

45.

Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.

Morishima Y, Kashiwase K, Matsuo K, Azuma F, Morishima S, Onizuka M, Yabe T, Murata M, Doki N, Eto T, Mori T, Miyamura K, Sao H, Ichinohe T, Saji H, Kato S, Atsuta Y, Kawa K, Kodera Y, Sasazuki T; Japan Marrow Donor Program.

Blood. 2015 Feb 12;125(7):1189-97. doi: 10.1182/blood-2014-10-604785. Epub 2014 Dec 17.

46.

Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.

Matsushita H, Yahata T, Sheng Y, Nakamura Y, Muguruma Y, Matsuzawa H, Tanaka M, Hayashi H, Sato T, Damdinsuren A, Onizuka M, Ito M, Miyachi H, Pandolfi PP, Ando K.

PLoS One. 2014 Nov 4;9(11):e111082. doi: 10.1371/journal.pone.0111082. eCollection 2014.

47.

Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's Lymphoma.

Kawada H, Sawanobori M, Tsuma-Kaneko M, Wasada I, Miyamoto M, Murayama H, Toyosaki M, Onizuka M, Tsuboi K, Tazume K, Shirasugi Y, Ohmachi K, Ogawa Y, Kobayashi H, Ando K.

Tokai J Exp Clin Med. 2014 Sep 20;39(3):111-5.

48.

P-gp modulating drugs greatly potentiate the in vitro effect of ivermectin against resistant larvae of Haemonchus placei.

Heckler RP, Almeida GD, Santos LB, Borges DG, Neves JP, Onizuka MK, Borges FA.

Vet Parasitol. 2014 Oct 15;205(3-4):638-45. doi: 10.1016/j.vetpar.2014.08.002. Epub 2014 Aug 18.

PMID:
25178553
49.

High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II study.

Oshiro Y, Okumura T, Kurishima K, Homma S, Mizumoto M, Ishikawa H, Onizuka M, Sakai M, Goto Y, Hizawa N, Sato Y, Sakurai H.

J Radiat Res. 2014 Sep;55(5):959-65. doi: 10.1093/jrr/rru034. Epub 2014 May 25.

50.

Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemia.

Mizuta S, Matsuo K, Nishiwaki S, Imai K, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Miyamura K, Takahashi S, Onizuka M, Atsuta Y, Suzuki R, Morishima Y, Kato K, Sakamaki H, Tanaka J.

Blood. 2014 Apr 10;123(15):2325-32. doi: 10.1182/blood-2013-11-538728. Epub 2014 Mar 3.

Supplemental Content

Loading ...
Support Center